Synthesis and evaluation of the structural elements in alkylated tetrahydroisoquinolines for binding to CNS receptors (original) (raw)
Design and synthesis of dual 5-HT1A and 5-HT7 receptor ligands
Kwakye Peprah
Bioorganic & Medicinal Chemistry, 2016
View PDFchevron_right
Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands
Holger Stark
Frontiers in Chemistry
View PDFchevron_right
Rational design of novel benzisoxazole derivatives with acetylcholinesterase inhibitory and serotoninergic 5-HT4 receptors activities for the treatment of Alzheimer’s disease
Sylvie Claeysen
Scientific Reports, 2020
View PDFchevron_right
Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors
Krzysztof Marciniec
European Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif
Christian Masaguer
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Synthesis and preliminary pharmacological evaluation of 5-Hydroxy- and 5,6-dihydroxy-1,2,3,7,12,12a-hexahydrobenzo[5,6]cyclohepta[1,2,3- ij]isoquinoline derivatives as dopamine receptor ligands
Grazia Luisi
Bioorganic Medicinal Chemistry, 2001
View PDFchevron_right
Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors
Vukic Soskic
European Journal of Medicinal Chemistry, 2008
View PDFchevron_right
Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors
Gilda Neves
Bioorganic & Medicinal …, 2010
View PDFchevron_right
Identification of a series of benzoxazoles as potent 5-HT6 ligands
Edward Kerns
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Development of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D3 Receptor Ligands
Holger Stark
ChemBioChem, 2004
View PDFchevron_right
2-{4-[ω-[4-(2-Methoxyphenyl)-1-piperazinyl]alkoxy]phenyl}-2H-benzotr iazoles and their N-Oxides as Ligands for some 5-Hydroxytryptamine, Dopamine and Adrenergic Receptor Subtypes
Fabio Sparatore
Pharmacy and Pharmacology Communications, 2000
View PDFchevron_right
Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics
Eduardo Domínguez
Bioorganic & Medicinal Chemistry Letters, 2007
View PDFchevron_right
2-{4-[ω-[4-(2-Methoxyphenyl)-1-piperazinyl]alkoxy]phenyl}-2 H -benzotr iazoles and their N-Oxides as Ligands for some 5-Hydroxytryptamine, Dopamine and Adrenergic Receptor Subtypes
Fabio Sparatore
Pharmacy and Pharmacology Communications, 2000
View PDFchevron_right
Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor
Sebastián Rojas
Journal of Molecular Modeling, 2017
View PDFchevron_right
Synthesis and Pharmacological Evaluation of Tetrahydroisoquinoline-Hydantoin Derivatives as Selective σ1 Ligands
Julie Charton
View PDFchevron_right
Tetrahydroisoquinolines as dopaminergic ligands: 1Butyl7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice
Vanessa Romero
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure
Maurizio Anzini
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Facile synthesis of octahydrobenzo[h]isoquinolines: Novel and highly potent D1 dopamine agonists
David Nichols
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
The influence of substitution at aromatic part of 1,2,3,4-tetrahydroisoquinoline on in vitro and in vivo 5-HT1A/5-HT2A receptor activities of its 1-adamantoyloaminoalkyl derivatives
Anna Wesołowska
Bioorganic & Medicinal Chemistry, 2002
View PDFchevron_right
Design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands
Lucio Schiapparelli
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
Benzimidazole derivatives. Part 5: Design and synthesis of new benzimidazole–arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands
Lucio Schiapparelli
Bioorganic & Medicinal Chemistry, 2004
View PDFchevron_right
Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation
Krzysztof Marciniec
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right